Menu

First Investments in the Women's Fund: GC Therapeutics

A pioneer in scalable, cutting-edge cell therapies

parastoo K
Written by

Shivani Singh

Published on

Read

1 min

Meet Parastoo Khoshakhlagh, the pioneering CEO of GC Therapeutics, a biotech innovator leveraging synthetic biology and AI to accelerate the development of life-saving therapies. As a remarkable portfolio company of Alumni Ventures’ Women’s Fund 1, GC Therapeutics is transforming the future of healthcare and medicine. In this video, we’ll explore Parastoo’s groundbreaking vision, the science behind GC Therapeutics, and how her leadership is advancing the frontiers of biotechnology. Discover how this investment exemplifies the power of supporting women-led ventures pushing boundaries in healthcare innovation.

See video policy below.

Written by

Shivani Singh

Shivani Singh's investment experience spans a range of sectors, including enterprise software, defense tech, and healthcare, where she has invested across growth and early-stage opportunities. She began her career at Google, where she quickly advanced to Senior Product Manager, launching major products such as Google Meet and the Pixel phone. Shivani holds a B.S. in Computer Engineering from the University of Illinois Urbana-Champaign and an MBA from Harvard Business School.

LinkedIn
Tagged with

Follow us

AV Headquarters
670 N. Commercial Street
Suite 403
Manchester, NH 03101
General inquiries: [email protected]

Press inquiries: [email protected]

603-518-8112

Follow us

Neither Alumni Ventures nor any of its funds are sponsored by, affiliated with, or otherwise endorsed by any university. For further details see our Legal & Privacy Policy.

Video Policy: By consuming this content I acknowledge that I may be considering an investment with AV funds for my own or my client’s account. I agree that information contained herein may not be relied upon or used for any other purpose. Offers to purchase securities are only made through formal offering documents, which describe risks (which are significant), terms, and other important information that must be considered before an investment decision is made. To see Important Disclosure Information, visit: https://av-funds.com/disclosures.

Testimonial/Endorsement Policy: Testimonials/Endorsements were provided by the participants without compensation, but each participant has a relationship with Alumni Ventures (AV) from which they benefit. All views expressed are the individual’s own and do not represent the experience of all AV fund investors or companies in which AV funds invest. Please note that testimonials are no guarantee of future performance or success. Any provider of an endorsement that is affiliated with a portfolio company Alumni Ventures has received investment funding from AV, and may in the future seek and/or receive additional funding from AV. This circumstance constitutes a conflict of interest. Providers of testimonials or endorsements were not chosen at random or according to any objective basis, but rather on the basis of their relationship with AV.

Investor Portal Update Policy: Investor portfolio data is updated once per quarter in the AV Investor Portal.

Alumni Ventures is America’s largest VC firm for individual investors based on the combination of total capital raised, number of investments, and number of investors of leading VC firms as reported by Pitchbook and other publicly available information reviewed by AV.

(1) Internal Rate of Return (IRR) for AV Funds is net of management fees and incentive allocations applied to amounts distributed to investors, and gross of incentive allocations applicable to unrealized gains on investments held by AV Funds. IRR for AV Funds includes uninvested cash, unrealized investments, and amounts distributed to investors. The IRR shown for the Russell 2000 indices are gross of fees because indices are not managed investments, and it is not possible to invest directly in an index. For additional information see av-funds.com/disclosures. All investment involves risk, including risk of loss. Past performance is not necessarily indicative of future results. For more information on AV Funds’ investment returns, please see here.

Not an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are only made pursuant to the formal offering documents for the fund, that describe the risks (which are significant), terms, and other important information that must be considered before an investment decision is made.
To see additional risk factors and investment considerations, visit: https://av-funds.com/disclosures.

Please click here to view additional investor policies.

© 2025, Alumni Ventures. All rights reserved.